HCT–ASCT confirmed as standard-of-care consolidation therapy for PCNSL

David Killock

Open source

DOI
10.1038/s41571-026-01197-0
Published
2026-08-07
Container
Nature Reviews Clinical Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41571-026-01197-0,
  title = {HCT–ASCT confirmed as standard-of-care consolidation therapy for PCNSL},
  author = {David Killock},
  year = {2026},
  journal = {Nature Reviews Clinical Oncology},
  doi = {10.1038/s41571-026-01197-0},
  url = {https://doi.org/10.1038/s41571-026-01197-0}
}

RIS

TY  - JOUR
TI  - HCT–ASCT confirmed as standard-of-care consolidation therapy for PCNSL
AU  - David Killock
PY  - 2026
JO  - Nature Reviews Clinical Oncology
DO  - 10.1038/s41571-026-01197-0
UR  - https://doi.org/10.1038/s41571-026-01197-0
ER  - 

APA

Killock, D. (2026). HCT–ASCT confirmed as standard-of-care consolidation therapy for PCNSL. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-026-01197-0

Source records